Tumor Biology

, Volume 36, Issue 6, pp 4509–4518 | Cite as

Clinical significance of Sam68 expression in endometrial carcinoma

Research Article


Sam68 (Src-associated in mitosis of 68 kDa) is a substrate for tyrosine kinase c-Src during mitosis. The nuclear protein level has been found to be associated with progression and prognosis in various human malignant tumors. The aim of this study is to investigate the clinical value of Sam68 in endometrial carcinoma (EC). Sam68 expression was confirmed by real-time PCR, Western blot, and immunofluorescent assay in primary normal endometrial epithelial cells, endometrial carcinoma cell lines, as well as seven pairs of EC and matched adjacent noncancerous endometrial tissues. Moreover, the protein level of Sam68 was evaluated by immunohistochemistry in a cohort of surgical specimens derived from 131 patients including primary endometrial carcinoma (n = 95), endometrial atypical hyperplasia (precancerous lesions, n = 26), and normal endometria (n = 10). In endometrial cancer cell lines, RNA interfering approach was employed to downregulate Sam68 expression to determine its role in proliferation. Clinicopathological relevance and prognostic associations were examined by statistical analyses. Compared with normal endometrial and endometrial atypical hyperplasia tissues, Sam68 significantly elevated in endometrial cancer samples (P < 0.01), which was negative or low in 37 cases (38.9 %) and high in 58 cases (61.1 %). The high expression of Sam68 was associated with histological grade (P < 0.001), FIGO stage (P = 0.039), and myometrial invasion (P = 0.002). Kaplan–Meier analysis demonstrated that overexpression of Sam68 correlated with shorter overall survival. It is confirmed by univariate and multivariate analysis (P < 0.001 and P = 0.048, respectively). Additionally, we found that Sam68 was highly expressed at both the transcriptional and translational levels in endometrial cancer cell lines (Ishikawa, HEC-1B, AN3CA, KLE, and RL95-2) and siRNA knockdown of Sam68 remarkably inhibited cellular proliferation in in vitro models. Sam68 may be useful prognostic marker for EC, and it plays an important role in promoting the cellular proliferation. Further investigation of Sam68 as a potential therapeutic target for EC patients could be of interest.


Sam68 Endometrial carcinoma Proliferation Survival 



This study was supported by grants from the Shanghai Science and Technology Committee Foundation (13ZR1432000) and the Foundation of Shanghai Municipal Health Bureau (YQ 2012-009).

Conflicts of interest


Supplementary material

13277_2015_3095_MOESM1_ESM.doc (36 kb)
ESM 1 (DOC 36 kb)
13277_2015_3095_MOESM2_ESM.doc (38 kb)
ESM 2 (DOC 38 kb)
13277_2015_3095_MOESM3_ESM.doc (54 kb)
ESM 3 (DOC 53 kb)


  1. 1.
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol. 2003;21:4214–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004;35:649–62.CrossRefPubMedGoogle Scholar
  4. 4.
    Werner HM, Salvesen HB. Current status of molecular biomarkers in endometrial cancer. Curr Oncol Rep. 2014;16:403.CrossRefPubMedGoogle Scholar
  5. 5.
    Matias-Guiu X, Davidson B. Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Arch. 2014;464:315–31.CrossRefPubMedGoogle Scholar
  6. 6.
    Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA. A target for src in mitosis. Nature. 1994;368:871–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Sanchez-Jimenez F, Sanchez-Margalet V. Role of Sam68 in post-transcriptional gene regulation. Int J Mol Sci. 2013;14:23402–19.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bielli P, Busa R, Paronetto MP, Sette C. The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocr Relat Cancer. 2011;18:R91–102.CrossRefPubMedGoogle Scholar
  9. 9.
    Najib S, Martin-Romero C, Gonzalez-Yanes C, Sanchez-Margalet V. Role of Sam68 as an adaptor protein in signal transduction. Cell Mol Life Sci. 2005;62:36–43.CrossRefPubMedGoogle Scholar
  10. 10.
    Bedford MT, Frankel A, Yaffe MB, Clarke S, Leder P, Richard S. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem. 2000;275:16030–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Taylor SJ, Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature. 1994;368:867–71.CrossRefPubMedGoogle Scholar
  12. 12.
    Taylor SJ, Anafi M, Pawson T, Shalloway D. Functional interaction between c-Src and its mitotic target, Sam 68. J Biol Chem. 1995;270:10120–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Maa MC, Leu TH, Trandel BJ, Chang JH, Parsons SJ. A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma. Mol Cell Biol. 1994;14:5466–73.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Richard S, Yu D, Blumer KJ, Hausladen D, Olszowy MW, Connelly PA, et al. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1. Mol Cell Biol. 1995;15:186–97.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Espejo A, Cote J, Bednarek A, Richard S, Bedford MT. A protein-domain microarray identifies novel protein–protein interactions. Biochem J. 2002;367:697–702.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Trub T, Frantz JD, Miyazaki M, Band H, Shoelson SE. The role of a lymphoid-restricted, Grb2-like SH3–SH2–SH3 protein in T cell receptor signaling. J Biol Chem. 1997;272:894–902.CrossRefPubMedGoogle Scholar
  17. 17.
    Richard S, Vogel G, Huot ME, Guo T, Muller WJ, Lukong KE. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene. 2008;27:548–56.CrossRefPubMedGoogle Scholar
  18. 18.
    Bianchi E, Barbagallo F, Valeri C, Geremia R, Salustri A, De Felici M, et al. Ablation of the Sam68 gene impairs female fertility and gonadotropin-dependent follicle development. Hum Mol Genet. 2010;19:4886–94.CrossRefPubMedGoogle Scholar
  19. 19.
    Paronetto MP, Messina V, Bianchi E, Barchi M, Vogel G, Moretti C, et al. Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis. J Cell Biol. 2009;185:235–49.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Song L, Wang L, Li Y, Xiong H, Wu J, Li J, et al. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells. J Pathol. 2010;222:227–37.CrossRefPubMedGoogle Scholar
  21. 21.
    Busa R, Paronetto MP, Farini D, Pierantozzi E, Botti F, Angelini DF, et al. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene. 2007;26:4372–82.CrossRefPubMedGoogle Scholar
  22. 22.
    Classen-Linke I, Kusche M, Knauthe R, Beier HM. Establishment of a human endometrial cell culture system and characterization of its polarized hormone responsive epithelial cells. Cell Tissue Res. 1997;287:171–85.CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, et al. Expression and cytoplasmic localization of Sam68 is a significant and independent prognostic marker for renal cell carcinoma. Cancer Epidemiol Biomark Pre. 2009;18:2685–93.CrossRefGoogle Scholar
  24. 24.
    Zhang Z, Xu Y, Sun N, Zhang M, Xie J, Jiang Z. High Sam68 expression predicts poor prognosis in non-small cell lung cancer. Clin Transl Oncol. 2014;16:886–91.CrossRefPubMedGoogle Scholar
  25. 25.
    Li Z, Yu CP, Zhong Y, Liu TJ, Huang QD, Zhao XH, et al. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol. 2012;23:638–46.CrossRefPubMedGoogle Scholar
  26. 26.
    Liao WT, Liu JL, Wang ZG, Cui YM, Shi L, Li TT, et al. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer. BMC Gastroenterol. 2013;13:126.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY, et al. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol. 2008;215:67–77.CrossRefPubMedGoogle Scholar
  28. 28.
    Zhao X, Li Z, He B, Liu J, Li S, Zhou L, et al. Sam68 is a novel marker for aggressive neuroblastoma. OncoTargets Ther. 2013;6:1751–60.Google Scholar
  29. 29.
    Liu K, Li L, Nisson PE, Gruber C, Jessee J, Cohen SN. Neoplastic transformation and tumorigenesis associated with Sam68 protein deficiency in cultured murine fibroblasts. J Biol Chem. 2000;275:40195–201.CrossRefPubMedGoogle Scholar
  30. 30.
    Taylor SJ, Resnick RJ, Shalloway D. Sam68 exerts separable effects on cell cycle progression and apoptosis. BMC Cell Biol. 2004;5:5.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li ZH, et al. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis. 2011;32:1419–26.CrossRefPubMedGoogle Scholar
  32. 32.
    Cheng C, Sharp PA. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol. 2006;26:362–70.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Cappellari M, Bielli P, Paronetto MP, Ciccosanti F, Fimia GM, Saarikettu J, et al. The transcriptional co-activator snd1 is a novel regulator of alternative splicing in prostate cancer cells. Oncogene. 2014;33:3794–802.CrossRefPubMedGoogle Scholar
  34. 34.
    Paronetto MP, Cappellari M, Busa R, Pedrotti S, Vitali R, Comstock C, et al. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the rna-binding protein Sam68. Cancer Res. 2010;70:229–39.CrossRefPubMedGoogle Scholar
  35. 35.
    Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, et al. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol. 2010;191:87–99.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Modem S, Chinnakannu K, Bai U, Reddy GP, Reddy TR. Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells. J Cell Physiol. 2011;226:2747–51.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Qingying Wang
    • 1
  • Yue Li
    • 1
  • Jianhong Zhou
    • 1
  • Jie Liu
    • 1
  • Jinlong Qin
    • 1
  • Feng Xing
    • 1
  • Jiawen Zhang
    • 1
  • Jiajing Cheng
    • 1
  1. 1.Department of Obstetrics and Gynecology, Shanghai Tenth People’s HospitalTongji University School of MedicineShanghaiChina

Personalised recommendations